醫療影像及報告實作指引 - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: DiagnosticReportLC - XML Representation

Raw xml | Download

<DiagnosticReport xmlns="http://hl7.org/fhir">
  <id value="DiagnosticReportLC"/>
  <meta>
    <profile
             value="https://hapi.fhir.tw/fhir/StructureDefinition/DiagnosticReport-LC"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: DiagnosticReport DiagnosticReportLC</b></p><a name="DiagnosticReportLC"> </a><a name="hcDiagnosticReportLC"> </a><a name="hcDiagnosticReportLC-en-US"> </a><h2><span title="Codes:{http://loinc.org 22637-3}">Pathology report final diagnosis Narrative</span> (<span title="Codes:{http://loinc.org LP7839-6}">Pathology</span>) </h2><table class="grid"><tr><td>Subject</td><td>No display for Patient </td></tr><tr><td>Reported</td><td>2021-06-23 14:35:32+0000</td></tr><tr><td>Performer</td><td> <a href="Practitioner-TWCorePractitioner.html">Practitioner 大吉 連 (official)</a></td></tr><tr><td>Identifier</td><td> <code>https://www.vghtpe.gov.tw/</code>/123456</td></tr></table><p><b>Report Details</b></p><table class="grid"><tr><td><b>Code</b></td><td><b>Value</b></td><td><b>Flags</b></td><td><b>When For</b></td></tr><tr><td><a href="Observation-GrossFinding.html"><span title="Codes:{http://loinc.org 22634-0}">Pathology report gross observation Narrative</span></a></td><td>The specimen received in formalin has 3 parts. Part (A) consists of a piece of lung, labeled RLL segment and measures 6.5 x 3.3 x1.8 cm. A gray white firm tumor, 1.2 x 0.5 x 0.5 cm, is noted 0.8 cm from the bronchial cut end, 0.1 cm from visceral pleura.Part (B) consists of groups of lymph nodes labeled as above.Part (C) is a piece of lung labeled 'RLL margin', measuring 3.8x 1.8 x 1 cm. Representative parts are taken for sections in 5 blocks. (A:bronchial and vascular cut end, B:stapled margin,C:tumor, D:specimen labeled 'RLL margin', E:interlobar LNs)(WKW)</td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Histologictype.html"><span title="Codes:{http://loinc.org 33731-1}">Histology type in Cancer specimen Narrative</span></a></td><td><span title="Codes:{https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-Morphology 81402}, {https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-Morphology 85503}">adenocarcinoma,acinar predominant</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Histologicpattern.html"><span title="Codes:{http://snomed.info/sct 255711007}">Pattern (attribute)</span></a></td><td><span title="Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-Histologic-pattern acinar}, {https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-Histologic-pattern lepidic}">acinar(90%),lepidic(10%)</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Celltype.html"><span title="Codes:{http://loinc.org 32760-1}">Cell type in Specimen</span></a></td><td>non-mucinous tumor cells</td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Resectionmargin.html"><span title="Codes:{http://loinc.org 21939-4}">Surgical margins cancer involvement</span></a></td><td>free of tumor involvement</td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Nontumorousparenchyma.html"><span title="Codes:{http://snomed.info/sct 113255004}">Structure of parenchyma of lung (body structure)</span></a></td><td>congestion</td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Totaltumorsize.html"><span title="Codes:{http://loinc.org 21889-1}">Size Tumor</span></a></td><td>0.6x0.4cm</td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Sizeofinvasivefocus.html"><span title="Codes:{http://loinc.org 33759-2}">Deepest extent of invasion [Type] in Specimen</span></a></td><td>0.6 cm<span style="background: LightGoldenRodYellow"> (Details: UCUM  codecm = 'cm')</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Angiolymphaticinvasion.html"><span title="Codes:{http://loinc.org 59544-7}">Lymph-vascular invasion Cancer specimen</span></a></td><td><span title="Codes:{http://loinc.org LA9634-2}">absent</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Perineuralinvasion.html"><span title="Codes:{http://loinc.org 92837-4}">Perineural invasion [Presence] in Cancer specimen</span></a></td><td><span title="Codes:{http://loinc.org LA9634-2}">absent</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Pleuralinvasion.html"><span title="Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-MicroscopicFinding Pleural-invasion}">Pleural invasion</span></a></td><td><span title="Codes:{http://loinc.org LA9634-2}, {https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-Pleural-Invasion PL0}">absent(PL0)</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-SpreadThroughAirSpaces.html"><span title="Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-MicroscopicFinding STAS}">Spread Through Air Spaces(STAS)</span></a></td><td><span title="Codes:{http://loinc.org LA9634-2}">absent</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Tumornecrosis.html"><span title="Codes:{http://snomed.info/sct 34823008}">Tumor necrosis (morphologic abnormality)</span></a></td><td><span title="Codes:{http://loinc.org LA9634-2}">absent</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Tcategory.html"><span title="Codes:{http://loinc.org 21899-0}">Primary tumor.pathology Cancer</span></a></td><td><span title="Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-pT T1a}">tumor &lt;=1 cm or less in greatest dimension(pT1a)</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Lymphnodes.html"><span title="Codes:{http://loinc.org 21900-6}">Regional lymph nodes.pathology [Class] Cancer</span></a></td><td><span title="Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-pN N0}">all without metastatic tumor(pN0)</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Metastasis.html"><span title="Codes:{http://loinc.org 21901-4}">Distant metastases.pathology [Class] Cancer</span></a></td><td><span style="color: maroon" title="Error">Error: <b><span title="Codes:{http://terminology.hl7.org/CodeSystem/data-absent-reason unknown}">unknown</span></b></span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Pathologicalstaging.html"><span title="Codes:{http://loinc.org 21914-7}">Stage group.other Cancer</span></a></td><td><span title="Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-pTNM IA1}">pT1aN0</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Tumorgrading.html"><span title="Codes:{http://snomed.info/sct 397005006}">World Health Organization tumor classification (observable entity)</span></a></td><td><span title="Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-Grading G2}">Grade group 2 (microscopic measurement)</span></td><td>Final</td><td>2021-06-21</td></tr><tr><td><a href="Observation-Ancillarystudies.html"><span title="Codes:{https://hapi.fhir.tw/fhir/CodeSystem/NSCLC-MicroscopicFinding Ancillary}">Ancillary studies</span></a></td><td>Tumor cell positive for TTF-1 and negative for p40;Multinucleate giant cell negative for CK</td><td>Final</td><td>2021-06-21</td></tr></table><p>Adenocarcinoma, acinar predominant, pT1aN0</p></div>
  </text>
  <identifier>
    <system value="https://www.vghtpe.gov.tw/"/>
    <value value="123456"/>
  </identifier>
  <status value="final"/>
  <category>
    <coding>
      <system value="http://loinc.org"/>
      <code value="LP7839-6"/>
      <display value="Pathology"/>
    </coding>
  </category>
  <code>
    <coding>
      <system value="http://loinc.org"/>
      <code value="22637-3"/>
      <display value="Pathology report final diagnosis Narrative"/>
    </coding>
  </code>
  <subject>🔗 
    <reference value="Patient/TWCorePatient"/>
  </subject>
  <encounter>🔗 
    <reference value="Encounter/TWCoreEncounter"/>
  </encounter>
  <issued value="2021-06-23T14:35:32.631Z"/>
  <performer>🔗 
    <reference value="Practitioner/TWCorePractitioner"/>
  </performer>
  <resultsInterpreter>🔗 
    <reference value="Practitioner/TWCorePractitioner"/>
  </resultsInterpreter>
  <specimen>🔗 
    <reference value="Specimen/TWCoreSpecimen"/>
  </specimen>
  <result>🔗 
    <reference value="Observation/GrossFinding"/>
  </result>
  <result>🔗 
    <reference value="Observation/Histologictype"/>
  </result>
  <result>🔗 
    <reference value="Observation/Histologicpattern"/>
  </result>
  <result>🔗 
    <reference value="Observation/Celltype"/>
  </result>
  <result>🔗 
    <reference value="Observation/Resectionmargin"/>
  </result>
  <result>🔗 
    <reference value="Observation/Nontumorousparenchyma"/>
  </result>
  <result>🔗 
    <reference value="Observation/Totaltumorsize"/>
  </result>
  <result>🔗 
    <reference value="Observation/Sizeofinvasivefocus"/>
  </result>
  <result>🔗 
    <reference value="Observation/Angiolymphaticinvasion"/>
  </result>
  <result>🔗 
    <reference value="Observation/Perineuralinvasion"/>
  </result>
  <result>🔗 
    <reference value="Observation/Pleuralinvasion"/>
  </result>
  <result>🔗 
    <reference value="Observation/SpreadThroughAirSpaces"/>
  </result>
  <result>🔗 
    <reference value="Observation/Tumornecrosis"/>
  </result>
  <result>🔗 
    <reference value="Observation/Tcategory"/>
  </result>
  <result>🔗 
    <reference value="Observation/Lymphnodes"/>
  </result>
  <result>🔗 
    <reference value="Observation/Metastasis"/>
  </result>
  <result>🔗 
    <reference value="Observation/Pathologicalstaging"/>
  </result>
  <result>🔗 
    <reference value="Observation/Tumorgrading"/>
  </result>
  <result>🔗 
    <reference value="Observation/Ancillarystudies"/>
  </result>
  <imagingStudy>🔗 
    <reference value="ImagingStudy/ImagingStudyBase"/>
  </imagingStudy>
  <conclusion value="Adenocarcinoma, acinar predominant, pT1aN0"/>
</DiagnosticReport>